Indications |
Oral Skin and soft tissue infections Adult: 500 mg once daily for 3 days. Alternatively, 500 mg as a single dose on the 1st day followed by 250 mg once daily for 4 days. Child: >6 mth: 10 mg/kg; 15-25 kg: 200 mg; 26-35 kg: 300 mg; 36-45 kg: 400 mg. Doses to be taken once daily for 3 days. Oral Respiratory tract infections Adult: 500 mg once daily for 3 days. Alternatively, 500 mg as a single dose on the 1st day followed by 250 mg once daily for 4 days. Child: >6 mth: 10 mg/kg; 15-25 kg: 200 mg; 26-35 kg: 300 mg; 36-45 kg: 400 mg. Doses to be taken once daily for 3 days. Oral Uncomplicated genital infections due to Chlamydia trachomatis Adult: 1 g as a single dose. Oral Uncomplicated gonorrhoea Adult: 2 g as a single dose. Oral Prophylaxisof disseminated Mycobacterium avium complex (MAC) infections Adult: 1.2 g once every wk. For treatment or secondary prophylaxis: 500 mg once daily with other antimycobacterials. Child: >6 mth: 10 mg/kg once daily for 3 days. Oral Granuloma inguinale Adult: Initially, 1 g followed by 500 mg daily. Alternatively, 1 g once a wk for at least 3 wk, until all lesions have completely healed. Intravenous Active immunisation against typhoid fever caused by Salmonella typhi Adult: 500 mg once daily for 7 days. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Impaired liver and renal function; pregnancy and lactation; children. |
Adverse Reactions |
Mild to moderate nausea, vomiting, abdominal pain, dyspepsia, flatulence, diarrhoea, cramping; angioedema, cholestatic jaundice; dizziness, headache, vertigo, somnolence; transient elevations of liver enzyme values. |
Drug Interactions |
Antacids containing aluminium and magnesium salts reduce rate of absorption. Increased risk of ergot toxicity. Potentially Fatal: Increased serum concentrations of digoxin and ciclosporin. See Below for More azithromycin Drug Interactions |
Food Interactions |
Food may alter absorption. |
Mechanism of Actions |
Azithromycin blocks transpeptidation by binding to 50s ribosomal subunit of susceptible organisms and disrupting RNA-dependent protein synthesis at the chain elongation step. Absorption: Reduced by food (capsule formulation); peak plasma concentrations after 2-3 hr. Distribution: Extensive into the tissues (concentrations higher than those in blood), WBC (high concentrations), CSF (small amounts). Metabolism: Liver (demethylation). Excretion: Via the bile (as unchanged drug and metabolites); via the urine (6% of the dose). Elimination half-life: about 68 hr. |
Administration |
Tab & susp: May be taken with or without food. (May be taken w/ meals to reduce GI discomfort.) Cap & extended release microspheres: Should be taken on an empty stomach. (Take on an empty stomach 1 hr before or 2 hr after meals.) |
Storage Conditions |
Intravenous: Store below 30°C. Oral: Store below 30°C. |
ATC Classification |
J01FA10 - azithromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections. S01AA26 - azithromycin ; Belongs to the class of antibiotics. Used in the treatment of eye infections. |
Storage |
Intravenous: Store below 30°C. Oral: Store below 30°C. |
Available As |
|
Azithromycin
Post Review about Azithromycin Click here to cancel reply.
Azithromycin Containing Brands
Azithromycin is used in following diseases
Drug - Drug Interactions of Azithromycin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.